Free Trial

BioLargo Q4 2023 Earnings Report

BioLargo logo
$0.20 +0.02 (+11.42%)
(As of 12/20/2024 04:34 PM ET)

BioLargo EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioLargo Revenue Results

Actual Revenue
$4.37 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioLargo Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

BioLargo Earnings Headlines

BioLargo CEO Dennis Calvert appoints to Department of Commerce’s ETTAC
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
BioLargo Shares Strategic Updates in Investor Webcast
BioLargo reports Q3 revenue $4.4M vs. $2.7M last year
BioLargo (BLGO)
See More BioLargo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLargo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLargo and other key companies, straight to your email.

About BioLargo

BioLargo (NASDAQ:BLGO) invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

View BioLargo Profile

More Earnings Resources from MarketBeat

Upcoming Earnings